Cognitive dysfunction fairly common after COVID-19 infection

Sotrovimab cuts risk for COVID-19 progression in high-risk patients
29 October 2021
Needle-free COVID-19 vaccine shows promise
29 October 2021

Cognitive dysfunction fairly common after COVID-19 infection

(HealthDay)—A substantial proportion of relatively young COVID-19 survivors exhibit cognitive dysfunction several months after recovering from COVID-19, according to a research letter published online Oct. 22 in JAMA Network Open.

Comments are closed.